Interactions of dietary polyunsaturated fatty acids and vitamin E with regard to vitamin E status, fat composition and antibody responsiveness in layer hens.
1. Effects of dietary polyunsaturated fatty acids (PUFA) and vitamin E (VE) on an immune response may interact because VE may protect PUFA from in vivo oxidation. The present study was designed to study the presence of such an interaction in growing layer chickens. 2. Three dietary concentration of linoleic acid (LA, 3.3, 6.6 and 10%), in combination with 4 concentration of dietary VE (5, 20, 40 and 80 mg/kg) were used. Effects of LA and VE on circulating VE concentration, fatty acid composition of bursal and adipose fat, and antibody kinetics against keyhole limpet hemocyanin and Mycobacterim butyricum were established. 3. At high dietary LA concentration, bursal and adipose LA were higher but bursal arachidonic acid and long chain n-3 PUFA decreased. The dietary VE level did not consistently affect the deposition of PUFA in tissue. Plasma VE concentrations were affected by the dietary VE and LA content, but not by their interaction. Antibody responses before and 7 d after immunisation were affected by the dietary treatments. Antibody concentration were not affected by tissue fatty acid content. 4. In conclusion, the interaction effects of dietary PUFA and VE on fat deposition and immune responses are of minor importance compared to separate PUFA and VE effects. This implies that, within the studied range, adding extra VE to preserve or affect the effects of dietary PUFA on antibody responsiveness is unnecessary.
Sijben
J W C
JW
Adaptation Physiology Group, Wageningen Institute of Animal Sciences, Wageningen University, The Netherlands. john.sijben@genr.vh.wau.nl
Schrama
J W
JW
Nieuwland
M G B
MG
Hovenier
R
R
Beynen
A C
AC
Verstegen
M W A
MW
Parmentier
H K
HK
D000273:Adipose Tissue / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D000917:Antibody Formation / Q000187:drug effects*; D000975:Antioxidants / Q000494:pharmacology*; D002060:Bursa of Fabricius / Q000378:metabolism; D002645:Chickens / Q000254:growth & development / Q000276:immunology* / Q000378:metabolism; D004042:Dietary Fats, Unsaturated / Q000008:administration & dosage / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004306:Dose-Response Relationship, Immunologic; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage / Q000494:pharmacology; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006433:Hemocyanins / Q000276:immunology; D019787:Linoleic Acid / Q000008:administration & dosage; D009161:Mycobacterium / Q000276:immunology; D010084:Oxidation-Reduction / Q000187:drug effects; D011897:Random Allocation; D014810:Vitamin E / Q000097:blood / Q000494:pharmacology*
D000907:Antibodies, Bacterial; D000975:Antioxidants; D004042:Dietary Fats, Unsaturated; D015525:Fatty Acids, Omega-3; D005231:Fatty Acids, Unsaturated; D014810:Vitamin E; D006433:Hemocyanins; D019787:Linoleic Acid; C032808:keyhole-limpet hemocyanin